Views & Reviews Drug tales and other stories

Paying for the view

BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39457.434039.59 (Published 17 January 2008) Cite this as: BMJ 2008;336:160
  1. Ike Iheanacho, editor, Drug and Therapeutics Bulletin
  1. iiheanacho{at}bmjgroup.com

    It’s a wonder they can talk at all, given their mouths are so stuffed with industry gold. Somehow, though, they manage it, and often to great effect.

    Opinion leaders are megastars of the medical world. Groomed, pampered, and promoted by drug companies, they are the role models whose views are to be taken seriously.

    Such individuals are part of an elaborate game that supposedly ensures “transparency” about the relationships between doctors and their industry paymasters. The declarations of competing interests so …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe